Autoplay
Autocomplete
Previous Lesson
Complete and Continue
Legislation December 2024
Question
Question
Comments
Question 1 - Drug Classification
Question
a) A tablet containing 200mg paracetamol, 45mg caffeine, 200mg salicylamide, 5mg phenylpropanolamine hydrochloride and 2mg chlorphenamine maleate
b) Aspirin
c) Solifenacin
d) Chloramphenicol eardrop
e) tablet containing 5mg oxethazaine, 126mg dried aluminium hydroxide and 84mg magnesium carbonate
f) A cream containing 20% w/w azelaic acid
g) 50 mg nitrofurantoin and 100 mg phenazopyridine
h) 250mg paracetamol, 150mg ethenzamide and 50mg caffeine
i) Myrtol
j) A cream containing 0.64mg/g betamethasone dipropionate, 1.7mg/g gentamicin sulfate and 10mg/g clotrimazole
k) A syrup containing 1.67mg/5ml chlorphenamine maleate, 4.5mg/5ml codeine phosphate, 4mg/5ml ephedrine hydrochloride and 2.67mg/5ml bromhexine hydrochloride
l) Indapamide
m) Antacid containing hyoscine, dicycloverine, and chlordiazepoxide
n) A syrup containing 4mg/5ml ethylmorphine hydrochloride, 2mg/5ml chlorphenamine maleate, 2mg/5ml ephedrine hydrochloride, 75mg/5ml ammonium chloride and 0.1ml/5ml ipecacuanha
Summary
B) Part 1 Poisons
Question 2 - ASP vs LSP
Question
a) ASP vs LSP in the PPO
b) ASP vs LSP for P1 and P2 poisons
c) S3 restrictions
Question 3 - Dangerous Drugs Ordinance
Question
a) Definition
b) Hospitals - storage, supply, record keeping
Question 4 - Antibiotics Ordinance
Question
a) Substances to which AO applies
b) Control of sale and supply
c) Record keeping
Question 5 - Advanced Therapy Product
a) Definition
b) Labelling requirements
c) Clinical Trials
e) tablet containing 5mg oxethazaine, 126mg dried aluminium hydroxide and 84mg magnesium carbonate
Lesson content locked
If you're already enrolled,
you'll need to login
.
Enroll in Course to Unlock